Abstract
Hypothetical workflow of cardiac allograft rejection diagnostics after implementation of recent developments. New noninvasive screening methods for rejection diagnostics are being developed, such as detection of donor-specific and non-HLA (human leucocyte antigen) antibodies, leucocyte gene expression profiling, and circulating donor-derived cell-free DNA (ddcfDNA). When a rejection is suspected, endomyocardial biopsy
... read more